98%
921
2 minutes
20
The 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guideline lowered the threshold defining hypertension and treatment target from 140/90 mmHg to 130/80 mmHg. We compared the 2017 ACC/AHA guideline and the Eighth Joint National Committee (JNC8) report with regard to the current status of hypertension using the Korean National Health and Nutrition Examination Survey. The association between blood pressure (BP) control and long-term major cardiovascular outcomes (MACEs) was analyzed using the Korea National Health Insurance Service cohort. In the cross-sectional study with 15,784 adults, the prevalence of hypertension was expected to be 49.2 ± 0.6% based on the definition suggested by the 2017 ACC/AHA guideline versus 30.4 ± 0.6% based on the JNC8 report. In a longitudinal analysis with 373,800 hypertensive adults for the median follow-up periods of 11.0 years, the adults meeting the target goal BP goal of 2017 ACC/AHA guideline were associated with 21% reduced risk of MACEs compared with adults, not meeting 2017 ACC/AHA BP goal but meeting JNC8 target goal. In conclusion, substantial increase of prevalence of hypertension is expected by the 2017 ACC/AHA guideline. This study also suggests endorsing the aggressive approach would lead to an improvement in cardiovascular care.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120944 | PMC |
http://dx.doi.org/10.1038/s41598-018-31549-5 | DOI Listing |
Cureus
July 2025
Department of Physiology, People's College of Medical Sciences and Research Centre, Bhopal, IND.
Background Hypertension is a rising concern among young adults, driven by sedentary lifestyles, academic stress, and poor dietary habits. Medical students, despite being a theoretically low-risk group, exhibit a notable prevalence of elevated blood pressure. Traditional measures such as body mass index (BMI) fail to capture fat distribution, a critical determinant of cardiovascular risk.
View Article and Find Full Text PDFCureus
July 2025
Department of General Medicine, Pakistan Institute of Medical Sciences, Islamabad, PAK.
Background Undiagnosed hypertension among young adults is a growing public health concern, contributing silently to long-term cardiovascular morbidity. This study aimed to determine the prevalence of undiagnosed hypertension (Stage 1-2, previously unrecognized) and to assess statistically significant associations with lifestyle risk factors in a community-based young adult population. Methods A community-based, cross-sectional study was conducted at Hazrat Bari Sarkar (HBS) Medical and Dental College, Islamabad, Pakistan, from January to December 2023.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
August 2025
Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY (B.K.B., Y.Z., A.E.M.).
Background: Compared with the 2003 Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7) guideline, the 2017 American College of Cardiology and American Heart Association guideline (ACC/AHA 2017) expanded hypertension diagnostic criteria to blood pressure (BP) ≥130/80 mm Hg and intensified treatment goals to <130/80 mm Hg. The cost-effectiveness of ACC/AHA 2017 guideline treatment has not been quantified.
Methods: We used the Cardiovascular Disease (CVD) Policy Model to simulate hypertension treatment according to ACC/AHA 2017 compared with JNC7 in untreated US adults aged 35 to 79 years.
Hypertension
August 2025
American Geriatrics Society (AGS) Representative.
Aim: The "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults" retires and replaces the "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults."
Methods: A comprehensive literature search was conducted from December 2023 to June 2024 to identify clinical studies, reviews, and other evidence performed on human subjects that were published since February 2015 in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.
Structure: The focus of this clinical practice guideline is to create a living, working document updating current knowledge in the field of high blood pressure aimed at all practicing primary care and specialty clinicians who manage patients with hypertension.